Impax Securities Plaintiffs Seek To Finalize $9M Deal
Plaintiffs' lawyers are seeking final approval of a $9 million settlement involving allegations that generic-drug company Impax Laboratories Inc. artificially inflated the value of its stock by making false and misleading...To view the full article, register now.
Already a subscriber? Click here to view full article